KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Current Assets (2016 - 2025)

Evolent Health (EVH) has 11 years of Current Assets data on record, last reported at $570.1 million in Q3 2025.

  • For Q3 2025, Current Assets rose 4.79% year-over-year to $570.1 million; the TTM value through Sep 2025 reached $570.1 million, up 4.79%, while the annual FY2024 figure was $607.1 million, 11.2% down from the prior year.
  • Current Assets reached $570.1 million in Q3 2025 per EVH's latest filing, up from $562.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $727.9 million in Q1 2025 and bottomed at $463.4 million in Q1 2022.
  • Average Current Assets over 5 years is $569.8 million, with a median of $562.3 million recorded in 2025.
  • Peak YoY movement for Current Assets: skyrocketed 43.01% in 2023, then dropped 14.84% in 2024.
  • A 5-year view of Current Assets shows it stood at $524.0 million in 2021, then dropped by 8.76% to $478.1 million in 2022, then surged by 43.01% to $683.7 million in 2023, then dropped by 11.2% to $607.1 million in 2024, then fell by 6.1% to $570.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $570.1 million in Q3 2025, $562.3 million in Q2 2025, and $727.9 million in Q1 2025.